about
Statins for children with familial hypercholesterolemiaClinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reductionThe Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination TherapyApproach to asymptomatic creatine kinase elevationGenetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic reviewTreatment of dyslipidemia with statins and physical exercises: recent findings of skeletal muscle responsesMuscular effects of statins in the elderly female: a reviewPrimary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentStatin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementRhabdomyolysis: pathogenesis, diagnosis, and treatmentStatin-induced rhabdomyolysis: a comprehensive review of case reports.Pharmacogenomic insights into treatment and management of statin-induced myopathy.A Genomic DNA Reporter Screen Identifies Squalene Synthase Inhibitors That Act Cooperatively with Statins to Upregulate the Low-Density Lipoprotein ReceptorMyopathy in Patients Taking Atorvastatin: A Pilot Study.Safety of statins: an updateStatins and their interactions with other lipid-modifying medications: safety issues in the elderlyRhabdomyolysis after midazolam administration in a cirrhotic patient treated with atorvastatin.A family with diabetes and heart failure.Mechanisms and assessment of statin-related muscular adverse effects.The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia.Intermittent nondaily dosing strategies in patients with previous statin-induced myopathy.Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.Drug-related myopathies of which the clinician should be awareBioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens AitStatin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation.Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysisA case report of autoimmune necrotizing myositis presenting as dysphagia and neck swelling.Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.Quinine induced simvastatin toxicity through cytochrome inhibition - a case report.Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study.Electrophysiologic and clinico-pathologic characteristics of statin-induced muscle injury.Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control StudiesTreatment Options for Statin-Associated Muscle Symptoms.Clinical characteristics of acute renal failure with severe loin pain and patchy renal vasoconstriction.Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate.Sickle Cell Trait, Rhabdomyolysis, and Mortality among U.S. Army Soldiers.SLCO1B1 Polymorphisms and Statin-Induced Myopathy.
P2860
Q24194816-F705D84A-310B-475D-9F52-4FE1ECEE522DQ26752950-DF84D8FD-CF28-445E-A4CB-A66D1E7D7A1DQ26771168-4F009ED6-C020-4DFE-838B-3828EBDBDC68Q26772145-1EC10A19-8793-45CF-B7E8-5D54DE771644Q26823434-860EB18E-87E8-4B33-90B0-C8A7E5DE5DF9Q27006481-2D115774-ED6C-403C-889A-929BB50C7B3AQ27023343-55E905A0-012B-492E-899D-E1887389EC01Q28078384-4B6A93FA-4292-4EE8-BAB3-A5A54BD06179Q28083004-105331F2-1D54-44D5-A23D-E2551F928130Q28087634-7D9CE4B6-018C-4540-9CCC-452DFC7E1653Q33551640-8922570A-E257-4719-88A3-20229F54D69AQ33600104-30F50C1E-362E-47C5-A84C-AEBA3A3F36A4Q33724316-E5A5ABEE-9022-4A20-BA82-8677A93C8D6EQ33815469-ED898301-C42E-4D60-8741-545575BA7E12Q33949312-41247605-C8A8-4D0F-92EF-9AA949840792Q33949348-0FBFFD99-9290-4A56-AA85-C18CBDCA5301Q34047690-43B347D2-FB8E-48CA-8E4F-6CA765E2D1D0Q34524211-04EEF0D5-A290-47AE-B0E7-573F11166AB9Q34570995-7DCC8C22-614A-4EEE-B956-8DA279CDBC78Q34613443-D85FD6D4-F04F-4EB9-87B9-C36D00FBBFDBQ34625887-8119BF53-5C64-4709-8D9A-5E209ED7FBCEQ34649206-AE9C9C7E-9423-4630-A7B8-688D629F4DFBQ34680467-84C5F2BF-EC93-4CFD-ADB6-16B899A8DE97Q34974845-FA42E1BD-5A91-4D36-A9F5-B42715816BA4Q35155508-1E60F07B-35F2-4D92-8F75-7E9E872EFD64Q35232279-5A2C78B7-BC72-41F4-BEA3-8C77749FA755Q35245459-AED17E57-7E19-40E7-AD96-6C79BFFCC73DQ35766202-54F20EB8-96CD-4232-8BBB-9650A28BB659Q35799847-861F3E45-8832-4E49-AAF1-202FF6250EF3Q36020670-97C81C60-6BAD-4674-9EE0-9EA53F2857C8Q36072457-50842E29-A6A6-4310-8BDF-896EDF67EFD4Q36156619-25BCD21B-BCB7-469F-9C0B-2E68C960B734Q36211920-D8450B8D-D97B-44F5-B708-423B3AC22B5FQ36249326-7F4F900D-847B-4861-8ADB-5A7924DC476DQ36256049-844F766F-9564-4C08-88F7-E66F20CB6837Q36294394-BA186C90-1CDD-411C-B3F0-D0AE1DB3655DQ36471761-424F2945-26EF-45AD-88EF-1D0C86821AE5Q37226646-0C28864F-88A8-499D-8AE6-3110470E36FCQ37262144-7E374559-1F54-48A2-BECA-E1BB49CD6156Q37410969-AB4AEDDA-4043-47EB-A1CB-45795F53048B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Narrative review: statin-related myopathy.
@en
Narrative review: statin-related myopathy.
@nl
type
label
Narrative review: statin-related myopathy.
@en
Narrative review: statin-related myopathy.
@nl
prefLabel
Narrative review: statin-related myopathy.
@en
Narrative review: statin-related myopathy.
@nl
P1476
Narrative review: statin-related myopathy.
@en
P2093
Tisha R Joy
P304
P356
10.7326/0003-4819-150-12-200906160-00009
P407
P577
2009-06-01T00:00:00Z